GO:0042731 PH domain binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042731 PH domain binding describes the molecular function of binding to a pleckstrin homology (PH) domain, a ~100-residue module found in many signaling and cytoskeletal proteins.
• PH domains are best known for phosphoinositide recognition, but their binding specificity is broader and context-dependent, involving cooperativity with other lipids and protein partners.
• PH domain binding events regulate diverse processes including dynamin-mediated endocytosis, integrin outside-in signaling, Arf GTPase activation, and nuclear transcription.
• Dysregulation of PH domain interactions contributes to human diseases such as cancer, bleeding disorders, and metabolic dysfunction.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of PH domain binding in cells and organisms.
• EDITGENE provides end-to-end services for generating and screening PH domain binding-related cell models, from KO to library screening and bioinformatics.
Description
PH domain binding (GO:0042731) is a molecular function defined as binding to a pleckstrin homology (PH) domain, a compact protein module of approximately 100 residues that occurs in a wide range of proteins involved in intracellular signaling or as constituents of the cytoskeleton. PH domains are among the most common phosphoinositide-binding modules in the human proteome, and their interactions with lipids and proteins are central to signal transduction, membrane trafficking, and cytoskeletal dynamics. The term captures any protein-protein or protein-lipid interaction that targets a PH domain, including binding by regulatory partners, inhibitors, or lipid ligands. Understanding PH domain binding is therefore critical for researchers studying how cells decode membrane signals and organize signaling complexes. Experimental evidence shows that PH domain binding is not a simple binary event but is modulated by lipid cooperativity, allostery, and structural polymorphism. For example, the PH domain of dynamin participates in endocytosis and is regulated by SH3 domain interactions, while the PH domain of kindlin-3 binds paxillin to support integrin outside-in signaling in platelets. Small-molecule inhibitors that target PH domain binding of BRAG2 can disrupt Arf GTPase signaling, highlighting the druggability of this function. In this article, we synthesize authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0042731, its mechanisms, key genes, disease relevance, and CRISPR-based methods for functional interrogation.
PH domain binding At A Glance
| GO ID | GO:0042731 |
|---|---|
| GO term | PH domain binding |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Binding to a PH domain (pleckstrin homology) of a protein, a domain of about 100 residues that occurs in a wide range of proteins involved in intracellular signaling or as constituents of the cytoskeleton. |
| Major function | Mediates protein-protein and protein-lipid interactions that target PH domain-containing proteins in signaling and cytoskeletal regulation. |
| Domain size | Approximately 100 residues. |
| Representative proteins | Dynamin, kindlin-3, BRAG2, TFIIH subunits, ORP8S. |
| Disease relevance | Cancer, bleeding disorders, metabolic and signaling pathologies. |
What Is GO:0042731?
According to the Gene Ontology, PH domain binding (GO:0042731) is the molecular function of binding to a PH domain (pleckstrin homology) of a protein, a domain of about 100 residues that occurs in a wide range of proteins involved in intracellular signaling or as constituents of the cytoskeleton. In practice, this means the term annotates any gene product that physically interacts with a PH domain, whether through protein-protein contacts, lipid-mediated recruitment, or allosteric modulation.
Why Is PH domain binding Important in Cell Biology?
PH domain binding is important because PH domains are ubiquitous interaction hubs that translate membrane lipid signals into cellular responses, and their binding partners determine the specificity, timing, and location of signaling events. Disrupting these interactions can alter endocytosis, integrin signaling, GTPase activation, and transcription, with direct consequences for human disease. As a result, PH domain binding is a focal point for both basic research and therapeutic development.
• PH domains are present in hundreds of human proteins, making PH domain binding a widespread regulatory mechanism.
• Phosphoinositide binding by PH domains is a canonical membrane-targeting signal, but binding specificity is redefined by cooperativity with other lipids such as PS.
• PH domain binding regulates dynamin function in endocytosis and SH3-mediated interactions.
• Kindlin-3 PH domain binding to paxillin is required for integrin αIIbβ3 outside-in signaling in platelets.
• Inhibitors of PH domain binding can disrupt Arf GTPase signaling, demonstrating pharmacological tractability.
• Structural polymorphism of PH domains, as seen in TFIIH, affects partner recognition and function.
• ORP8S requires its PH domain for localization to PM-ER contact sites, linking PH domain binding to lipid transfer.
• Dysregulated PH domain interactions are implicated in cancer, bleeding disorders, and metabolic diseases.
• CRISPR screens and edited cell models enable systematic interrogation of PH domain binding networks.
Molecular Mechanism of PH domain binding
Lipid Recognition and Membrane Recruitment
In simple terms: PH domains often grab specific lipids in the membrane to pull proteins to the right place.
PH domains are classic phosphoinositide-binding modules, and their interaction with lipids such as PIP2 and PS is a key mode of PH domain binding. Recent work shows that cooperativity between PIP2 and PS lipids modulates PH domain binding, meaning that lipid composition fine-tunes recruitment. Redefining the specificity of phosphoinositide-binding by human PH domain-containing proteins has revealed that many PH domains bind lipids with broader or different preferences than previously thought.
Protein-Protein Interactions with PH Domains
In simple terms: PH domains also bind other proteins, not just lipids.
Beyond lipids, PH domains engage in protein-protein interactions that are essential for signaling. For example, the PH domain of dynamin participates in SH3 binding domain interactions that regulate dynamin function. Kindlin-3 binds paxillin through its PH domain, and this interaction is required to support integrin αIIbβ3 outside-in signaling in platelets. These examples illustrate that PH domain binding can be direct and structurally specific.
Allosteric and Structural Polymorphism
In simple terms: PH domains can change shape, which affects what they bind.
PH domains are not rigid; structural polymorphism can alter their binding properties. In TFIIH, the PH domain exhibits structural polymorphism that may influence its interactions within the transcription machinery. Such conformational flexibility means that PH domain binding is often regulated by context, post-translational modifications, or partner-induced fit.
Regulation by Nucleotide Exchange and GTPases
In simple terms: Some PH domain interactions control small GTPase switches.
PH domain binding can regulate nucleotide exchange factors. Inhibitors of PH domain binding of BRAG2, a nucleotide exchange factor, disrupt Arf GTPase signaling, showing that blocking PH domain interactions can modulate GTPase cycles. This links PH domain binding directly to small GTPase activation and downstream trafficking events.
Membrane Contact Sites and Lipid Transfer
In simple terms: PH domains help proteins find contact points between organelles.
PH domains are also required for localization to membrane contact sites. Both the PH domain and N-terminal region of oxysterol-binding protein related protein 8S (ORP8S) are required for localization to PM-ER contact sites, implicating PH domain binding in lipid transfer and organelle communication.
Key Genes Involved in GO:0042731 PH domain binding
The following genes and proteins represent key players in PH domain binding, based on verified literature and their roles in signaling, cytoskeletal regulation, and disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DNM1 | Dynamin GTPase involved in endocytosis; PH domain and SH3 binding domains regulate function | Model for endocytosis and membrane remodeling |
| KIND3 (FERMT3) | Kindlin-3 PH domain binds paxillin to support integrin αIIbβ3 outside-in signaling | Platelet signaling and bleeding disorders |
| BRAG2 (IQSEC1) | Nucleotide exchange factor for Arf GTPases; PH domain binding inhibitors disrupt signaling | Arf GTPase signaling and inhibitor development |
| TFIIH subunits | PH domain structural polymorphism in TFIIH affects transcription | Transcription and DNA repair studies |
| OSBPL8 (ORP8S) | PH domain required for localization to PM-ER contact sites | Lipid transfer and membrane contact sites |
| PXN | Paxillin binds kindlin-3 PH domain in integrin signaling | Focal adhesion and integrin signaling |
| ITGA2B | Integrin αIIb subunit partner in outside-in signaling | Platelet function and thrombosis |
| ITGB3 | Integrin β3 subunit partner in outside-in signaling | Platelet function and thrombosis |
| ARF6 | Arf GTPase regulated by BRAG2 PH domain binding | Membrane trafficking |
| ARF1 | Arf GTPase family member potentially regulated by BRAG2 | GTPase signaling |
| SH3 domain proteins | SH3 domains interact with dynamin PH domain region | Protein interaction networks |
| PIP2 | Phosphoinositide lipid that binds PH domains | Lipid signaling |
| PS | Phosphatidylserine lipid that cooperates with PIP2 in PH domain binding | Membrane lipid studies |
| PLEK | Pleckstrin, prototype PH domain protein | PH domain structure and function |
| AKT1 | Kinase with PH domain that binds PIP3 | Cell survival signaling |
| BTK | Kinase with PH domain involved in B-cell signaling | Immunodeficiency and cancer |
| GRP1 (CYTH3) | Arf exchange factor with PH domain | Phosphoinositide specificity |
How Is PH domain binding Regulated?
PH domain binding is regulated at multiple levels. Lipid composition, particularly the cooperativity between PIP2 and PS, modulates PH domain binding to membranes. Phosphoinositide specificity is redefined by the intrinsic properties of each PH domain, and post-translational modifications or protein partners can further tune binding. Structural polymorphism, as observed in TFIIH, provides another layer of regulation. Additionally, nucleotide exchange factor activity, such as that of BRAG2, can be controlled by PH domain binding inhibitors, indicating that small molecules can regulate these interactions.
PH domain binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FERMT3 (KIND3) | Platelet dysfunction and bleeding disorders | Knockout or point-mutation in megakaryocytes |
| BRAG2 (IQSEC1) | Cancer and Arf GTPase signaling | Knockout or inhibitor-treated cancer cell lines |
| DNM1 | Endocytosis defects and neurological disorders | Knockout or knock-in in neuronal cells |
| OSBPL8 | Metabolic and lipid transfer disorders | Knockout or tagged knock-in in hepatocytes |
| AKT1 | Cancer and cell survival signaling | Overexpression or point-mutation in cancer models |
PH Domain Binding in Cancer
PH domain-containing proteins such as AKT and BTK rely on PH domain interactions for membrane recruitment and activation, and dysregulation of these pathways is common in cancer. Inhibitors that target PH domain binding, such as those for BRAG2, can disrupt Arf GTPase signaling, which is implicated in tumor progression. Thus, PH domain binding is a potential therapeutic target in oncology.
PH Domain Binding in Bleeding Disorders
Kindlin-3 PH domain binding to paxillin is required for integrin αIIbβ3 outside-in signaling in platelets. Defects in this interaction can lead to platelet dysfunction and bleeding disorders, making it a focus for hematology research.
PH Domain Binding in Metabolic and Signaling Diseases
ORP8S requires its PH domain for localization to PM-ER contact sites, which are important for lipid metabolism and signaling. Disruption of PH domain binding may contribute to metabolic dysfunction. Additionally, dynamin PH domain interactions are linked to endocytic defects observed in various diseases.
From PH domain binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PH domain binding affect endocytosis? | DNM1 knockout cell line |
| Does kindlin-3 PH domain binding to paxillin regulate integrin signaling? | FERMT3 point-mutation knock-in in platelets |
| Can BRAG2 PH domain binding be inhibited to disrupt Arf signaling? | BRAG2 knockout or inhibitor-treated cells |
| How does ORP8S PH domain contribute to PM-ER contact sites? | OSBPL8 tagged knock-in with imaging |
| What is the role of TFIIH PH domain polymorphism in transcription? | TFIIH subunit point-mutation knock-in |
| Which genes are essential for PH domain binding networks? | CRISPR library screening in signaling reporter cells |
How to Study the PH domain binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for PH domain binding | Identify novel regulators |
| Lipid overlay assay | Lipid binding specificity | Phosphoinositide profiling |
| Liposome binding assay | Affinity and cooperativity | PIP2/PS cooperativity |
| X-ray crystallography | 3D structure of PH domain complexes | Structural polymorphism |
| Live-cell imaging | Subcellular localization | PM-ER contact sites |
| Co-immunoprecipitation | Protein-protein interactions | Kindlin-3/paxillin binding |
| GTPase activation assay | Arf GTPase activity | BRAG2 inhibition |
CRISPR Knockout Screens
Genome-wide CRISPR knockout screens can identify genes required for PH domain binding-dependent processes, such as membrane recruitment or signaling output. These screens are particularly useful for uncovering novel regulators of PH domain interactions.
Lipid Binding Assays
Lipid overlay and liposome binding assays measure the specificity and affinity of PH domain binding to phosphoinositides and other lipids. Such assays have been used to redefine phosphoinositide specificity of human PH domains and to study PIP2/PS cooperativity.
Structural Biology
X-ray crystallography, NMR, and cryo-EM can resolve the structural basis of PH domain binding, including conformational changes and polymorphism. Structural studies of TFIIH PH domain illustrate this approach.
Live-Cell Imaging
Fluorescence microscopy of GFP-tagged PH domains or their binding partners allows real-time visualization of membrane recruitment and contact site localization, as shown for ORP8S.
How CRISPR Can Be Used to Study GO:0042731 PH domain binding
Knockout
CRISPR knockout of genes encoding PH domain-containing proteins or their binding partners can abolish specific interactions and reveal their cellular functions. For example, knocking out FERMT3 would eliminate kindlin-3 PH domain binding to paxillin and impair integrin signaling.
Point Mutation
Point mutations can be introduced into the PH domain or its binding interface to disrupt binding while preserving protein expression. This approach is useful for testing the specific contribution of PH domain binding, as seen in studies of dynamin SH3 binding and BRAG2 inhibitors.
Knock-in
Knock-in of tagged PH domain proteins (e.g., GFP or HA) allows visualization and purification of complexes. Tagged knock-in of ORP8S has been used to study its localization to PM-ER contact sites.
Overexpression
Overexpression of wild-type or mutant PH domain proteins can amplify signaling or act as dominant-negative inhibitors. Overexpression of PH domain constructs has been used to study phosphoinositide binding specificity and dynamin function.
How EDITGENE Supports PH domain binding Research
Researchers studying PH domain binding-related genes often need to determine whether a candidate gene is causally involved in a specific signaling or disease process. This requires precise genetic models that can isolate the contribution of PH domain interactions from other functions of the protein.
Contact EDITGENE today to design your custom CRISPR model for PH domain binding research.
Frequently Asked Questions About PH domain binding
What is GO:0042731 PH domain binding?
GO:0042731 is a Gene Ontology molecular function term defined as binding to a pleckstrin homology (PH) domain, a ~100-residue module found in many signaling and cytoskeletal proteins.
What genes are involved in PH domain binding?
Key genes include DNM1, FERMT3 (kindlin-3), IQSEC1 (BRAG2), OSBPL8, and TFIIH subunits, among others.
How does PH domain binding regulate cell signaling?
PH domain binding recruits proteins to membranes via lipid interactions and mediates protein-protein interactions that control GTPase activation, integrin signaling, and transcription.
What diseases are associated with PH domain binding?
Dysregulated PH domain binding is implicated in cancer, bleeding disorders, and metabolic diseases.
What methods are used to study PH domain binding?
Common methods include lipid overlay assays, structural biology, live-cell imaging, and CRISPR screens.
Can CRISPR be used to study PH domain binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of PH domain interactions.
What is the role of PIP2 in PH domain binding?
PIP2 is a phosphoinositide that binds PH domains, and its cooperativity with PS modulates binding affinity.
How do BRAG2 inhibitors affect PH domain binding?
BRAG2 inhibitors block PH domain binding and disrupt Arf GTPase signaling, showing pharmacological potential.
What is the structural basis of PH domain binding?
PH domains are ~100 residues and can exhibit structural polymorphism, as seen in TFIIH, affecting partner recognition.
Why is PH domain binding important for drug discovery?
Because PH domain interactions are central to signaling and disease, they are attractive targets for small-molecule inhibitors.
Conclusion
PH domain binding (GO:0042731) is a fundamental molecular function that governs how cells interpret lipid and protein signals to control endocytosis, integrin signaling, GTPase activation, and transcription. Its dysregulation contributes to cancer, bleeding disorders, and metabolic diseases, making it a compelling target for basic and translational research. Advances in CRISPR-based models and screening technologies now enable precise interrogation of PH domain binding networks, and EDITGENE offers comprehensive services to support these efforts.
References
- 1. Scaife RM et al.. 1997. The role of the PH domain and SH3 binding domains in dynamin function.. Cell Signal 9(6):395-401 PMID: 9376220
- 2. Chen X et al.. 2025. Cooperativity of PIP2 and PS lipids modulates PH domain binding.. Biophys J 124(7):1146-1157 PMID: 40012203
- 3. Singh N et al.. 2021. Redefining the specificity of phosphoinositide-binding by human PH domain-containing proteins.. Nat Commun 12(1):4339 PMID: 34267198
- 4. Nguyen HTT et al.. 2021. Paxillin binding to the PH domain of kindlin-3 in platelets is required to support integrin αIIbβ3 outside-in signaling.. J Thromb Haemost 19(12):3126-3138 PMID: 34411430
- 5. Nawrotek A et al.. 2019. PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling.. Nat Chem Biol 15(4):358-366 PMID: 30742123
- 6. Powis G et al.. 2023. Pleckstrin Homology [PH] domain, structure, mechanism, and contribution to human disease.. Biomed Pharmacother 165:115024 PMID: 37399719
- 7. Okuda M et al.. 2023. Structural polymorphism of the PH domain in TFIIH.. Biosci Rep 43(7) PMID: 37340985
- 8. Lee M et al.. 2018. Both the PH domain and N-terminal region of oxysterol-binding protein related protein 8S are required for localization to PM-ER contact sites.. Biochem Biophys Res Commun 496(4):1088-1094 PMID: 29409900
